DE69737032D1 - Mutanten von streptococcaltoxinen und vefahren zu deren anwendung - Google Patents

Mutanten von streptococcaltoxinen und vefahren zu deren anwendung

Info

Publication number
DE69737032D1
DE69737032D1 DE69737032T DE69737032T DE69737032D1 DE 69737032 D1 DE69737032 D1 DE 69737032D1 DE 69737032 T DE69737032 T DE 69737032T DE 69737032 T DE69737032 T DE 69737032T DE 69737032 D1 DE69737032 D1 DE 69737032D1
Authority
DE
Germany
Prior art keywords
spe
toxin
methods
vaccine
streptococcaltoxines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737032T
Other languages
English (en)
Inventor
M Schlievert
Manuela Roggiani
Jennifer Stoehr
Douglas Ohlendorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Application granted granted Critical
Publication of DE69737032D1 publication Critical patent/DE69737032D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69737032T 1996-12-06 1997-12-05 Mutanten von streptococcaltoxinen und vefahren zu deren anwendung Expired - Lifetime DE69737032D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3293096P 1996-12-06 1996-12-06
PCT/US1997/022228 WO1998024911A2 (en) 1996-12-06 1997-12-05 Mutants of streptococcal toxin a and methods of use

Publications (1)

Publication Number Publication Date
DE69737032D1 true DE69737032D1 (de) 2007-01-11

Family

ID=21867628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737032T Expired - Lifetime DE69737032D1 (de) 1996-12-06 1997-12-05 Mutanten von streptococcaltoxinen und vefahren zu deren anwendung

Country Status (11)

Country Link
US (2) US6913755B2 (de)
EP (1) EP0948624B1 (de)
JP (1) JP2001505439A (de)
KR (1) KR100548663B1 (de)
CN (1) CN1211487C (de)
AT (1) ATE346860T1 (de)
AU (1) AU7625798A (de)
BR (1) BR9714641A (de)
CA (1) CA2273822A1 (de)
DE (1) DE69737032D1 (de)
WO (1) WO1998024911A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
CN1211487C (zh) * 1996-12-06 2005-07-20 明尼苏达大学董事会 链球菌毒素a突变体及其使用方法
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US6872394B1 (en) 1997-12-02 2005-03-29 Idaho Research Foundation, Inc. Non-toxic immune stimulating enterotoxin compositions
US20040236082A1 (en) * 2001-04-13 2004-11-25 Marshall Matthew J. Modified staphylococcal enterotoxins and expression systems therefore
SE0102327D0 (sv) * 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
EP1461433A1 (de) * 2001-11-26 2004-09-29 U.S. Medical Research Institute of Infectious Diseases Bakterielle superantigen-impfstoffe
CN101622224B (zh) * 2007-03-01 2015-10-07 巴斯夫欧洲公司 借助eddn生产teta的新方法
KR20180100412A (ko) 2016-01-10 2018-09-10 네오티엑스 테라퓨틱스 엘티디. 면역강화제에 의해 증진되는 초항원 매개된 암 면역요법
WO2019218022A1 (en) * 2018-05-16 2019-11-21 Griffith University Streptococcal toxic shock syndrome
AU2020275142A1 (en) 2019-05-15 2021-12-16 Neotx Therapeutics Ltd. Cancer treatment
CN115484978A (zh) 2020-03-05 2022-12-16 尼奥克斯医疗有限公司 使用免疫细胞治疗癌症的方法和组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172126A (en) * 1976-11-08 1979-10-23 Sankyo Company Limited Method for the inactivation of microbial toxins and attenuation of vaccines
US4784948A (en) 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US5298396A (en) 1989-11-15 1994-03-29 National Jewish Center For Immunology And Respiratory Medicine Method for identifying T cells disease involved in autoimmune disease
US5336598A (en) 1989-11-15 1994-08-09 National Jewish Center For Immunology And Respiratory Medicine Method for diagnosing a superantigen caused pathologial condition via assay of T-cells
JPH08500328A (ja) 1992-01-28 1996-01-16 ナショナル ジューイッシュ センター フォア イミュノロジィ アンド レスパラトリィ メディスン 突然変異したスーパー抗原の保護作用
DK0832241T3 (da) 1995-06-07 2005-08-01 Univ Minnesota Streptokoktoksin A-mutanter og anvendelsesfremgangsmåder
CN1211487C (zh) * 1996-12-06 2005-07-20 明尼苏达大学董事会 链球菌毒素a突变体及其使用方法

Also Published As

Publication number Publication date
CN1246151A (zh) 2000-03-01
WO1998024911A3 (en) 1998-08-20
EP0948624B1 (de) 2006-11-29
US20020086813A1 (en) 2002-07-04
JP2001505439A (ja) 2001-04-24
ATE346860T1 (de) 2006-12-15
US6913755B2 (en) 2005-07-05
WO1998024911A2 (en) 1998-06-11
EP0948624A2 (de) 1999-10-13
CA2273822A1 (en) 1998-06-11
AU7625798A (en) 1998-06-29
US20060041107A1 (en) 2006-02-23
CN1211487C (zh) 2005-07-20
BR9714641A (pt) 2002-01-22
KR100548663B1 (ko) 2006-02-03
KR20000069316A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
ATE291625T1 (de) Streptococcus toxinmutanten und verfahren zu deren anwendung
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
DE60033530D1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
DE69737032D1 (de) Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
BR9909110A (pt) Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
DE69735439D1 (de) Mutanten von streptococcaltoxin c und verfahren zu deren anwendung
EA200100024A1 (ru) Состав таблетки с делавирдином
ATE382693T1 (de) Impfstoffe gegen neurotoxine von clostridium botulinum
BR9806925A (pt) Emulsão óleo-em-água, uso de uma emusão óleo-em-água, composição cosmética e/ou dermatológica, processo de tratamento cosmético e uso dos derivados de 1,3,5-triazina
ES2164684T3 (es) Uso de antagonistas de taquiquininas en el tratamiento de emesis.
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
DE69524971D1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
DE69531731D1 (de) Neue pestizid-zusammenstellungen und bacillus thuringiensis stämme
ATE103979T1 (de) Menschliches lymphotoxin.
DK0647654T3 (da) Anomere fluor-ribosylaminer
BR9607202A (pt) Cepa de bacillus thuringiensis e processos para controlar uma praga de insetos de uma espécie da ordem dos coleopteros para potencializar a atividade pesticida de um pesticida relacionado a bacillus e para obter uma substáncia substancialmente pura
BR9814866A (pt) Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica
ES2183947T3 (es) Mutantes que producen un potencializador de la actividad pesticida de un bacillus.

Legal Events

Date Code Title Description
8332 No legal effect for de